Category: Nutritional & Digestive Drivers

Too much vitamin B6 can injure peripheral nerves, and the dose required is lower than most people assume. Health Canada’s safety review found a possible link between vitamin B6-containing non-prescription natural health products and peripheral neuropathy at daily doses of 10 mg or higher [1]. The catch is that no blood level settles the question, so this is identified by exposure history and symptom timeline rather than by a single lab result.

It is also one of the drivers most easily missed, because patients do not describe it as a supplement problem. They describe burning, numbness or electric sensations in the feet, which is the same vocabulary every other neuropathy driver uses.

Key points

• Pyridoxine toxicity causes a length-dependent, sensory-predominant axonal polyneuropathy [2].
• Health Canada identified a possible risk signal at daily doses of 10 mg or higher, in non-prescription natural health products [1].
• Plasma B6 level did not correlate with neuropathy severity in a 261-patient cohort, so the number alone does not confirm or exclude the cause [2].
• Toxicity has been reported at ordinary multivitamin doses taken over years [3].
• Neuropathy is a category, not a diagnosis. B6 excess can be one driver among several in the same person.

What the regulators found

Health Canada reviewed vitamin B6-containing health products for a possible link to peripheral neuropathy, prompted by published international cases at daily doses under 100 mg and by assessments from foreign regulators [1].

The review identified 17 cases of peripheral neuropathy (15 Canadian and 2 international) in patients taking vitamin B6-containing non-prescription health products (14 cases) or vitamin B6-containing prescription drugs (3 cases) [1]. Fifteen of those 17 did not meet the criteria for further assessment, and in the two that did, confounders and missing clinical information limited the analysis, so a link could not be excluded rather than confirmed [1].

Health Canada’s conclusion distinguishes between product types. It found a possible link for the non-prescription natural health products at daily doses of 10 mg or higher, and did not find sufficient evidence to establish a link for vitamin B6-containing prescription drugs [1]. Nine supporting articles in the scientific literature were reviewed alongside the case data [1].

Why a blood level does not settle it

This is the part that surprises people. In 261 patients with chronic idiopathic axonal polyneuropathy enrolled in the Peripheral Neuropathy Research Registry, plasma vitamin B6 level was not related to neuropathy severity [2].

There was no relationship between an elevated plasma B6 level and nerve conduction study results, examination findings including toe strength, vibration sense and deep tendon reflexes, or patient-reported numbness or pain intensity [2]. The authors concluded that moderately elevated levels, even in the 100 to 200 µg/L range, were not associated with significantly worse signs or symptoms, and that very few patients in the study exceeded 300 µg/L [2].

So a mildly high number is not proof, and a normal number is not exclusion. The exposure history and the timeline do more work than the assay.

Ordinary doses, taken long enough

A published case report describes a 73-year-old man with three years of progressive bilateral numbness and tingling in the lower extremities, plus new lightheadedness and dizziness, while taking a standard daily multivitamin supplying 6 mg of vitamin B6 [3].

His serum B6 was 259.9 nmol/L against a reference range of 20 to 125 nmol/L, and one month after stopping the multivitamin he reported that the dizziness had resolved and the numbness and tingling had improved slightly [3]. One case is not a rule, but it is a reason to read the label rather than assume a common product is inert.

How we evaluate it

Exposure mapping

We ask about every daily multivitamin, B-complex, energy formula and anything else that lists pyridoxine, and we record the milligram amount and how long it has been taken. Then we line that up against when the symptoms started and how they progressed.

Supplements are the category patients most often leave out of a medication history, because they are not thought of as drugs.

Pattern mapping

Small fiber involvement produces burning and sensory change; large fiber involvement shows up as numbness, unsteadiness and lost position sense. Which pattern dominates decides which testing is worth running.

We perform electrodiagnostic testing (EMG/NCS) on site. It characterizes large-fiber involvement and can be normal in small fiber neuropathy, so a normal study does not close the file.

The other drivers in the same room

Excess B6 rarely arrives alone. Metabolic injury, vitamin B12 deficiency, gluten-related mechanisms, chemotherapy exposure, alcohol and heavy metals all produce overlapping symptoms, and two drivers in one person is common. The full set is laid out in the hidden drivers of peripheral neuropathy.

Videonystagmography (VNG) is used as a diagnostic test of inner-ear balance function when unsteadiness is part of the picture. It is a test, not a treatment.

When to move faster

Rapidly progressive numbness, significant balance loss or new weakness should be evaluated promptly rather than watched. So should sensory change that is starting to interfere with walking.

Waiting to see whether it settles on its own is the most common reason people arrive later than they should have.

What treatment looks like when the driver is nutritional or toxic

The first move is reducing or stopping the exposure and confirming whether anything else is contributing. That is driver-level work, and nothing else in the plan substitutes for it.

After that, the work is the terrain the nerve depends on: perfusion so oxygen reaches the nerve, the metabolic pathways that keep producing injury, and the substrates repair requires. Class 4 photobiomodulation, class 3B cold laser and whole-body infrared are used as supportive components matched to the clinical picture, not as stand-alone answers.

Orthobiologic injections (PRP and BMAC) are offered in selected situations. Qutenza (capsaicin 8% patch) is FDA-approved in adults for neuropathic pain from postherpetic neuralgia and from diabetic peripheral neuropathy of the feet; use for a toxic or nutritional driver would be off-label. It is applied in clinic by a clinician and repeated no more often than every three months.

None of this is a promise of nerve regeneration or reversal. Recovery after a toxic exposure is variable and often partial.

Frequently asked questions

Can a daily multivitamin cause vitamin B6 toxicity?

It has been reported. In a published case report, a 73-year-old man developed progressive numbness and tingling in both legs over three years while taking a standard daily multivitamin, with a serum B6 of 259.9 nmol/L against a normal range of 20 to 125 nmol/L. What matters is the pyridoxine amount on the label and how long it has been taken. We perform the testing that sorts this out on site; see our services and on-site testing.

Will a blood level tell me whether B6 is the cause?

Not by itself. In 261 patients with chronic idiopathic axonal polyneuropathy, plasma B6 level was not related to neuropathy severity, examination findings or nerve conduction results. Exposure history and symptom timeline carry more weight than a single number. See functional B12 deficiency and neuropathy.

What do the symptoms look like?

Pyridoxine toxicity is known to cause a length-dependent, sensory-predominant axonal polyneuropathy, so numbness, burning and sensory change starting in the feet are the usual picture. That pattern overlaps with several other drivers, which is why the exposure history matters. See small fiber neuropathy symptoms and testing.

What should I ask a clinic that is evaluating me for this?

Ask whether they will review every supplement label for pyridoxine content, how they will build the exposure timeline, and what testing they will use to characterize the nerve involvement. An evaluation that skips the supplement bottle is not an evaluation. See how to choose a neuropathy specialist.

If I stop the supplement, will the symptoms go away?

It is not that predictable. In the published case report, dizziness resolved and the numbness and tingling improved slightly one month after the multivitamin was stopped. Recovery is variable, and no one should promise reversal. See peripheral neuropathy of the feet symptoms.

Next step

If your symptoms started or worsened after beginning a B-complex or multivitamin, that timeline is worth taking seriously. Five questions identify which driver is doing the most damage right now.

Sources

1. Health Canada. Summary Safety Review – Vitamin B6 Health Products – Assessing the Potential Risk of Peripheral Neuropathy. Drug and Health Products Portal, Government of Canada. Reviews conducted 2024-2025. https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1773147434487
2. Stewart SL, Thomas S, Höke E, Simpson D, Singleton JR, Höke A. Vitamin B6 levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy. Journal of the Peripheral Nervous System. 2022;27(1):31-37. doi:10.1111/jns.12480. https://pubmed.ncbi.nlm.nih.gov/34931740/
3. Paluszny A, Qiu S. Vitamin B6 toxicity secondary to daily multivitamin use: a case report. Cureus. 2023;15(11):e48792. doi:10.7759/cureus.48792. https://pmc.ncbi.nlm.nih.gov/articles/PMC10720370/

B12 is not the only nutrient whose absence damages peripheral nerves. A 2026 review in Current Nutrition Reports describes thiamine (vitamin B1) shortage producing conditions such as beriberi and Wernicke’s encephalopathy, and concludes that thiamine and B12 shortages are established risk factors for neuropathy while vitamin B6 behaves differently — excess rather than inadequate B6 is what correlates with neuropathic effects.¹ That is why “it must be B12” is often the wrong starting assumption, and why the practical work is naming which driver is active before anything is prescribed.

The short version

• Beyond B12 means B1 and B6 first. Thiamine shortage and B6 excess are both documented nerve problems.
• More supplement is not the answer. With B6, more is the mechanism of injury.
• Nutrition rarely acts alone. It sits alongside metabolic, autoimmune, toxic, and structural contributors.
• Absorption matters as much as intake. Alcohol use, weight-loss surgery, and metformin are all in the picture.
• Idiopathic is not a stopping point. It usually means the active driver has not been named yet.

Why B12 deficiency is not the whole story

Vitamin B12 deficiency is a genuine and important pathway. Cobalamin shortage impairs DNA synthesis and myelin formation, which is why it produces neurological complications.¹ But it is one pathway among several.

This matters because medication that quiets the signal does not repair the wiring. If the driver is nutritional, metabolic, toxic, autoimmune, or structural, the nerve stays under stress while the symptom is being managed.

The B-vitamin traps

The common mistake is assuming a low vitamin is always the same vitamin. B-vitamin balance can fail in both directions, and the direction changes what you should do next.

Vitamin B1 (thiamine): shortage with real neurologic consequences

Thiamine shortage produces conditions including beriberi and Wernicke’s encephalopathy.¹ The practical point for peripheral nerves is that nutritional drivers beyond B12 can be serious, not merely a mildly abnormal number on a panel.

Diet pattern, alcohol intake, malabsorption, and periods of increased nutritional demand all belong in the history, because they are what put thiamine at risk in the first place.

Vitamin B6 (pyridoxine): excess is the nerve problem

Here the direction reverses. The review reports that excessive rather than inadequate pyridoxine correlates with neuropathic effects, and that while the B6 association remains uncertain overall, surplus B6 carries a neurotoxic risk.¹

This is what a supplement-first approach tends to miss. If you are taking a high-dose B6 product, the nutritional contribution to your neuropathy may be coming from too much rather than too little, and the plan changes immediately.

Absorption and metabolism travel together

Digestive and metabolic problems disrupt absorption and downstream handling of nutrients, which is why nutrition is treated here as part of the overall evaluation rather than as a one-time supplement correction.

What the risk-factor literature says about who is affected

A 2026 review in Neurological Research and Practice describes polyneuropathy as a common neurological disorder whose incidence is rising, especially among older people, and identifies B-vitamin deficiencies, prediabetes, diabetes mellitus, obesity, and treatment-induced neuropathies as key contributing risk factors.² It also notes that these factors frequently interact, which complicates management.

That is the clinical reality behind driver mapping: more than one contributor is usually running, and naming only the loudest one leaves the rest in place. Several of the contributors that get overlooked are covered in our review of the hidden drivers behind peripheral neuropathy.

How nutritional drivers show up in symptoms

Timing and distribution give useful clues. A symmetrical, length-dependent pattern — toes first, then up the foot — points toward a systemic or metabolic cause rather than a single local injury.

Nutritional drivers can also present with small-fiber features: burning, hot-coal sensations, and symptoms that are worse at night. When the pattern and the laboratory results do not line up, that mismatch is itself information.

Why standard testing can look unremarkable

Standard nerve conduction studies measure the larger fibers. Someone with prominent burning and normal-looking studies is not a contradiction; it is a limitation of what that test was built to see.

Medication, surgical, and medical history belong in the evaluation

Some clinical situations raise nutritional vulnerability directly. The Current Nutrition Reports review notes that while these deficiencies remain prevalent in developing regions, alcohol abuse, weight-loss surgery, and metformin use increasingly drive them in wealthier nations.¹

So the history has to cover medications, gastrointestinal and surgical history, and actual dietary intake, not only the nerve symptoms. None of that is a reason to stop a prescribed medication on your own.

Chemotherapy and nutritional status together

Chemotherapy can injure nerves directly, and nutritional status often changes during and after cancer treatment. When both are present, they are treated as two contributors rather than one.

How we evaluate a suspected nutritional driver

Neuropathy is rarely caused by blood sugar alone, and it is rarely explained by a single laboratory value. Evaluation is structured to decide which driver is doing the most damage right now.

Electrodiagnostic testing (EMG/NCS) is performed on site. VNG (videonystagmography) is available as a diagnostic test of inner-ear balance function when dizziness or unsteadiness is part of the picture — it is a test, never a treatment. Metabolic and nutritional assessment runs alongside both.

What treatment looks like when the driver is nutritional

We do not promise nerve regeneration, reversal, or a cure. The work is reducing what is damaging the nerve and supporting the conditions in which function can improve.

Depending on the driver, the plan may include class 4 photobiomodulation, class 3B cold laser, or whole-body infrared alongside metabolic and nutritional care. Orthobiologic injections (PRP and BMAC) are offered here. No success rate is published for any of it.

When nutrition is the dominant driver, the goal is to identify the specific pattern, avoid a supplement that makes things worse, and support the conditions for repair — in that order.

Where we are and how to start

Regenerve is located at 4477 Woodson Rd #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport, and we see patients from across the St. Louis region, Missouri and Illinois. You can call or text (314) 886-5902, or email info@regenerve.com.

The free Nerve Damage Score is a five-question starting point. It will not diagnose a vitamin problem, but it organizes the driver question so the first visit can go somewhere useful.

Frequently asked questions

Which nutritional deficiencies besides B12 can damage peripheral nerves?

Thiamine (vitamin B1) is the clearest one: a 2026 review in Current Nutrition Reports describes thiamine shortage producing beriberi and Wernicke’s encephalopathy, and lists thiamine and B12 deficiencies as established risk factors for neuropathy.¹ Vitamin B6 is the reverse problem, because excess rather than shortage is what correlates with nerve injury. See why a “normal” B12 result can still be misleading.

Can too much vitamin B6 really cause neuropathy?

That is what the review reports: excessive rather than inadequate pyridoxine correlates with neuropathic effects, and while the B6 association overall remains uncertain, surplus B6 poses a neurotoxic risk.¹ It is worth reviewing every supplement you take before adding another one. See the drivers that are most often missed.

Can gluten sensitivity affect nerves even if my celiac test was negative?

A negative celiac test rules out celiac disease, not every gluten-related mechanism, and immune and absorption pathways can overlap. We look at the whole picture rather than stopping at one result. See what a negative celiac test does and does not settle.

Do statins, metformin, or weight-loss surgery matter here?

The Current Nutrition Reports review notes that alcohol use, weight-loss surgery, and metformin use are increasingly driving B-vitamin deficiencies in higher-income countries.¹ That is a reason to review medication and surgical history, not a reason to stop a prescribed medication on your own. See how statins and metformin intersect with nerve health.

Why do my feet still burn when my labs look normal?

One normal value does not clear the nutritional question, and mixed drivers are common: a nutritional gap can sit alongside a metabolic, autoimmune, or toxic contributor. Burning at night in particular often reflects small-fiber involvement, which standard nerve conduction studies do not measure. See small fiber neuropathy symptoms and testing.

Sources

1. B Vitamin Deficiencies and Associated Neuropathies. Current Nutrition Reports. 2026. https://doi.org/10.1007/s13668-025-00723-3 (thiamine shortage producing beriberi and Wernicke’s encephalopathy; cobalamin deficiency impairing DNA synthesis and myelin formation; excess rather than inadequate pyridoxine correlating with neuropathic effects; alcohol abuse, weight-loss surgery, and metformin use increasingly driving these deficiencies in wealthier nations).
2. Targeting risk factors and strategies for prevention of peripheral neuropathy: focus on B-vitamin deficiencies and metabolic diseases. Neurological Research and Practice. 2026. https://doi.org/10.1186/s42466-026-00466-8 (rising incidence of polyneuropathy, especially among older people; B-vitamin deficiencies, prediabetes, diabetes mellitus, obesity, and treatment-induced neuropathies as key risk factors).

Most people think of gluten as a digestive issue — a problem for the gut, felt as bloating or diarrhea. But some of the most important consequences of gluten sensitivity are neurological, and they can appear in people whose intestines seem perfectly fine. Gluten can injure the nervous system directly, producing peripheral neuropathy and balance problems even in the complete absence of celiac disease. This article explains the immune mechanism behind that, why standard celiac testing so often misses it, and what the evidence says about dietary elimination.

Gluten sensitivity is not only celiac disease

Celiac disease is an autoimmune reaction to gluten that damages the small intestine. But researchers — most prominently Dr. Marios Hadjivassiliou and colleagues in Sheffield, UK — have spent decades documenting a broader category of gluten-related disorders in which the primary target is not the gut but the nervous system. In many of these patients, intestinal biopsy is normal or near-normal, and yet the neurological damage is real and progressive.

This matters enormously, because a patient with gluten neuropathy who is told “your celiac test is negative, so gluten isn’t your problem” may continue eating the very trigger that is dismantling their nerves.

Molecular mimicry: how the immune system confuses nerves for gluten

The central mechanism is molecular mimicry. When the immune system mounts a response to gluten, it produces antibodies. In susceptible people, some of those antibodies cross-react with the body’s own tissues because a molecular structure in nervous tissue resembles the gluten fragment closely enough to be mistaken for it.

A key player is an enzyme family called transglutaminase. In celiac disease, the immune attack targets transglutaminase-2, concentrated in the gut. In gluten-related neurological disease, antibodies against transglutaminase-6 (TG6) — an isoform expressed in the nervous system — have been identified as a marker of the neural attack. Antibodies can also target the myelin that insulates nerves. The result is an immune assault on the peripheral nerves (neuropathy) and, in some patients, on the cerebellum, producing gluten ataxia — a loss of coordination and balance.

What gluten neuropathy feels like

Gluten neuropathy most often presents as a length-dependent sensory neuropathy: tingling, numbness, and burning that begin in the feet. Because it develops slowly and can occur without digestive symptoms, it is frequently mislabeled as idiopathic. When the cerebellum is involved, patients may notice unsteadiness, a wide-based gait, or clumsiness that they attribute to aging. The combination of an unexplained sensory neuropathy and subtle balance problems should raise the question of gluten sensitivity.

Why the celiac test misses it

Standard celiac screening looks for the intestinal form of the disease — typically tissue transglutaminase-2 (tTG) antibodies and evidence of gut damage. It is not designed to detect the neurological form. A patient can have a completely negative celiac panel and still be producing the TG6 and anti-myelin antibodies driving nerve injury. This is why a negative celiac test does not rule out gluten as a cause of neuropathy — a point explored further in the companion article on negative celiac testing.

Genetic testing (for the HLA-DQ2/DQ8 haplotypes that predispose to gluten sensitivity) and expanded antibody panels give a more complete picture than a routine celiac screen alone.

The role of strict elimination

Because the damage is driven by an ongoing immune response to gluten, the logical — and evidence-supported — intervention is strict, sustained gluten elimination. Hadjivassiliou’s group has reported that patients who adhere rigorously to a gluten-free diet can see stabilization and, in some cases, improvement of their neurological symptoms, while partial or inconsistent avoidance is often insufficient. Nerve tissue recovers slowly, so improvement, when it comes, unfolds over months, and the earlier the trigger is removed, the more function there is to preserve.

“Strict” is the operative word. Unlike a lifestyle preference, therapeutic gluten elimination for neurological disease means eliminating cross-contamination and hidden sources — not simply cutting back on bread. This is best done with dietary guidance and monitoring.

Where this fits in a root-cause evaluation

Gluten is one driver among several that can masquerade as idiopathic neuropathy. In a thorough workup it is evaluated alongside metabolic, toxic, and mechanical contributors, because more than one can be present at once. The value of identifying a gluten contribution is that it is, in principle, entirely removable — the trigger is on the plate.

Frequently asked questions

Key takeaways

• Gluten can injure nerves and the cerebellum directly, independent of celiac disease.
• The mechanism is immune molecular mimicry, with transglutaminase-6 antibodies marking the neural attack.
• Standard celiac tests do not detect the neurological form; a negative result does not clear gluten.
• Strict, sustained gluten elimination is the evidence-supported intervention, with slow, partial recovery possible.
• Gluten is evaluated alongside other neuropathy drivers, and is uniquely removable.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not make major dietary or medication changes without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Hadjivassiliou M, Grünewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72:560–563.
2. Hadjivassiliou M, et al. Transglutaminase-6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1740–1745.
3. Hadjivassiliou M, et al. Gluten neuropathy. Muscle Nerve / Brain (peripheral neuropathy series).
4. Hadjivassiliou M, et al. Neurologic deficits in patients with gluten sensitivity — role of strict gluten-free diet.

Note: match each reference to the specific paper at publication; the Sheffield group has an extensive body of work in this area.

One of the most treatable causes of peripheral neuropathy is also one of the most frequently missed — not because doctors don’t test for it, but because the usual test can read “normal” while the deficiency is doing real damage at the cellular level. This article explains why a serum B12 result can be misleading, which functional markers reveal what it hides, and the full roster of nutrients your nerves depend on to function and to heal.

Why a “normal” B12 can be wrong

The standard test measures the total amount of vitamin B12 circulating in your blood. The problem is that this number does not necessarily reflect how much B12 is actually available and working inside your cells. A substantial portion of measured B12 is bound to a protein that cannot deliver it to tissues, so the total can look adequate while the metabolically active supply is low. Reference ranges also vary, and results in the low-normal zone are commonly reported as fine even when a patient is symptomatic.

The consequence is a patient with the classic tingling, numbness, and imbalance of a B12-related neuropathy being told their levels are “normal,” while the underlying deficiency quietly progresses. Untreated, B12 deficiency can damage not only peripheral nerves but the spinal cord itself — and while early damage is reversible, advanced damage may not be.

The functional markers that tell the truth: MMA and homocysteine

To see what serum B12 hides, clinicians use functional markers — substances that accumulate when B12 is inadequate at the cellular level, regardless of what the total blood level says.

Methylmalonic acid (MMA). B12 is a required cofactor for the enzyme that processes methylmalonyl-CoA. When B12 is functionally deficient inside cells, this reaction stalls and MMA builds up. An elevated MMA is a sensitive and relatively specific sign of true B12 deficiency at the tissue level.

Homocysteine. B12 (along with folate and B6) is needed to convert homocysteine into methionine. When B12 is functionally low, homocysteine rises. Elevated homocysteine is less specific than MMA — it can also reflect folate or B6 deficiency — but together the two markers give a far more accurate picture than serum B12 alone.

Checking MMA and homocysteine can catch a functional deficiency that a normal B12 would have masked, allowing correction before permanent nerve or spinal-cord injury occurs.

Common reasons B12 runs low

Functional B12 deficiency is especially worth checking in several situations. Metformin, one of the most-prescribed diabetes medications, interferes with B12 absorption and can produce deficiency over years of use — a cruel irony in patients whose diabetes is already threatening their nerves. Acid-suppressing drugs (PPIs and H2 blockers) reduce the stomach acid needed to liberate B12 from food. Age reduces absorption, as can autoimmune (pernicious) causes, gastrointestinal surgery, and strict plant-based diets. Anyone with unexplained neuropathy and any of these risk factors deserves functional testing.

B12 is not alone: the nutrient team your nerves need

B12 gets the headlines, but nerves depend on a whole team of cofactors, and deficiency of any one can impair function or healing.

Thiamine (B1). Essential for glucose metabolism and mitochondrial energy production. Thiamine deficiency directly causes neuropathy, and it is often depleted in diabetes and in heavy alcohol use. The work of Dr. Hammes and colleagues highlighted how thiamine-dependent pathways protect against the biochemical damage of high blood sugar — part of the rationale for the thiamine derivative benfotiamine.

Vitamin B6. Required for nerve function and neurotransmitter synthesis — but with an important caveat: both deficiency and excess can cause neuropathy, so B6 supplementation should be measured and monitored, not open-ended.

Magnesium. A cofactor in hundreds of enzymatic reactions, including those governing nerve excitability and mitochondrial energy. Deficiency contributes to nerve hyperexcitability and is common in diabetes.

Omega-3 fatty acids. Structural components of nerve membranes with anti-inflammatory effects; adequate intake supports the membrane integrity and the inflammatory balance that healthy nerves require.

The mitochondrial common thread

Notice the recurring theme: nearly every one of these nutrients feeds into mitochondrial energy production. A nerve is an energy-intensive structure, and it fails when its power supply falters. This is why correcting deficiencies is not simply “topping up vitamins” — it is restoring the cell’s ability to make energy, repair itself, and maintain its signaling. Functional nutrient testing, and correction guided by that testing, is a foundational part of a root-cause neuropathy plan rather than an afterthought.

What to do with this information

The practical message is to test properly and correct precisely. That means functional markers (MMA, homocysteine) rather than serum B12 alone, evaluation of thiamine and magnesium status, a review of medications that deplete these nutrients (without stopping needed prescriptions on your own), and repletion tailored to what the testing shows. Because some deficiencies (like B6) can harm in excess, and because absorption problems may require specific forms or routes of supplementation, this is best done under medical guidance.

Frequently asked questions

That is the subject of Peripheral Neuropathy: The 11 Hidden Drivers Your Doctor Missed.

Key takeaways

• A “normal” serum B12 can hide a cellular deficiency that damages nerves and even the spinal cord.
• Functional markers — methylmalonic acid and homocysteine — reveal true tissue-level deficiency.
• Metformin, acid-suppressing drugs, age, and GI issues are common causes worth screening for.
• Nerves also depend on thiamine, B6 (in balance), magnesium, and omega-3s, mostly via mitochondrial energy.
• Test functionally and correct precisely, under guidance — don’t self-dose blindly.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication or supplement without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368:149–160.
2. Aroda VR, et al. Long-term metformin use and vitamin B12 deficiency (Diabetes Prevention Program Outcomes Study). J Clin Endocrinol Metab. 2016.
3. Hammes HP, et al. Benfotiamine blocks three major pathways of hyperglycemic damage. Nat Med. 2003;9:294–299.
4. Ghavanini AA, Kimpinski K. Revisiting the evidence for neuropathy caused by pyridoxine (B6) deficiency and excess. J Clin Neuromuscul Dis. 2014.

You did the responsible thing. You mentioned your burning feet, someone ordered a celiac panel, it came back negative, and gluten was crossed off the list. But for a large number of people with gluten-related nerve damage, that negative result is exactly where the diagnosis goes wrong. The celiac test is answering a different question than the one your nerves are asking. This article explains why standard celiac screening misses gluten neuropathy, and what testing actually reveals it.

The celiac test answers the wrong question

Celiac disease is defined by an immune attack on the small intestine. Its screening tools are built to detect that — chiefly antibodies to tissue transglutaminase-2 (tTG-2), the transglutaminase isoform concentrated in the gut, confirmed by intestinal biopsy showing damage to the villi.

Gluten-related neurological disease is a different manifestation of gluten sensitivity. The immune response targets the nervous system, and the gut may be entirely spared. A patient can therefore have a pristine celiac panel and normal intestinal biopsy while producing the antibodies that are injuring their peripheral nerves. The test isn’t broken — it’s simply looking in the wrong place.

What the immune system actually targets in the nerves

As covered in the companion article on the gluten–neuropathy connection, the mechanism is molecular mimicry. Two targets are especially relevant to a nerve-focused workup.

Transglutaminase-6 (TG6). This isoform is expressed in nervous tissue, and antibodies against it — described by Dr. Marios Hadjivassiliou’s group — mark the neurological form of gluten sensitivity. TG6 antibodies can be present when the gut-focused tTG-2 antibodies are absent, which is precisely why a celiac screen can miss neurological disease.

Anti-myelin and related antibodies. The immune response can also target components of the myelin sheath that insulates nerves, contributing to the sensory neuropathy and, when the cerebellum is involved, the ataxia seen in gluten-related neurological disease.

The genetics: HLA-DQ2 and HLA-DQ8

Gluten sensitivity has a strong genetic underpinning. The great majority of people who react to gluten — whether the celiac or the neurological form — carry one of two immune-system genetic markers, HLA-DQ2 or HLA-DQ8. Testing for these haplotypes is informative in a different way than antibody testing: a negative HLA-DQ2/DQ8 result makes gluten-driven disease very unlikely and can effectively rule it out, while a positive result establishes susceptibility (though not everyone who is susceptible develops disease). This makes HLA typing a useful gatekeeping test in an unexplained neuropathy workup.

Building a proper gluten-neuropathy panel

For someone with an unexplained sensory neuropathy — especially with any balance disturbance — a more complete evaluation than a routine celiac screen includes HLA-DQ2/DQ8 genetic typing, an expanded gluten-related antibody panel (including TG6 where available, alongside the conventional celiac antibodies), and a clinical assessment for the length-dependent sensory pattern and any cerebellar signs. The aim is to catch the neurological form that the standard screen is not designed to see.

An important practical caveat: antibody testing is most meaningful while gluten is still in the diet. If a patient has already gone gluten-free, antibody levels may fall and produce falsely reassuring results — something to plan around with a clinician before testing.

Why it’s worth the effort

Chasing down a gluten contribution is worthwhile because, unlike many drivers of neuropathy, it is entirely removable — the trigger is dietary. When gluten-related neurological disease is confirmed and strict elimination is undertaken early, symptoms can stabilize and sometimes improve. The tragedy of the missed diagnosis is that the person keeps eating the trigger for years, attributing their progressive nerve damage to bad luck or aging, when a change on the plate could have changed the trajectory.

This is one driver among several

Gluten sensitivity is one possible contributor evaluated within a broader root-cause investigation that also weighs metabolic, toxic, and mechanical causes. Because multiple drivers frequently coexist, ruling gluten in or out is part of assembling the complete picture rather than a search for a single culprit.

Frequently asked questions

Key takeaways

• Standard celiac tests detect intestinal disease, not the neurological form of gluten sensitivity.
• Transglutaminase-6 (TG6) antibodies mark the neural attack and can be present with a negative celiac panel.
• HLA-DQ2/DQ8 typing is a useful gatekeeper: a negative result largely rules gluten out.
• Test while still eating gluten, since prior elimination can produce falsely negative antibodies.
• Confirmed gluten neuropathy is uniquely treatable, because the trigger is removable.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not make major dietary or medication changes without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Hadjivassiliou M, et al. Transglutaminase-6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1740–1745.
2. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318–330.
3. Hadjivassiliou M, et al. Gluten-related neurological dysfunction and HLA associations.
4. Volta U, et al. Serological tests in gluten-related disorders. Cell Mol Immunol / review.

Some neuropathies trace back to an event that happened years earlier — an operation that solved one problem while quietly setting up another. Surgeries that alter the digestive tract, including bariatric (weight-loss) procedures and gallbladder removal, can impair the absorption of nutrients the nervous system depends on. The nerve damage may appear months or years later, long after anyone is thinking about the surgery, which is exactly why the deficiency so often goes unchecked. This article explains how it happens, which nutrients are at risk, and why lifelong monitoring is the answer.

How digestive surgery leads to nerve damage

Nutrient absorption is a choreographed process that depends on specific parts of the digestive tract, specific stomach secretions, and — for fats and fat-soluble vitamins — bile. Surgery that changes this anatomy or physiology can disrupt absorption even when a person eats well.

Bariatric surgery works partly by reducing how much you eat and, in some procedures, by bypassing sections of the intestine where nutrients are absorbed. It also reduces stomach acid and intrinsic factor, both needed to absorb vitamin B12. The result is a well-documented, long-term risk of multiple nutrient deficiencies.

Gallbladder removal (cholecystectomy) changes how bile is delivered to the intestine. Because bile is essential for absorbing dietary fat and the fat-soluble vitamins (A, D, E, and K), some people develop impaired fat absorption afterward, which over time can affect nutrients like vitamin E — a deficiency specifically linked to neurological problems.

The common thread is malabsorption: the food goes in, but the nutrients don’t fully get where they need to go.

The nutrients at risk — and the nerves they protect

Several deficiencies after digestive surgery are directly relevant to nerve health.

Vitamin B12. Highly vulnerable after procedures that reduce stomach acid and intrinsic factor. B12 deficiency causes a characteristic neuropathy and can damage the spinal cord.

Thiamine (B1). Can become deficient rapidly, especially with vomiting or poor intake after surgery, and thiamine deficiency causes neuropathy and, acutely, can precipitate the neurological emergency Wernicke’s encephalopathy. This is one to catch early.

Copper. An underrecognized but important one. Copper deficiency — which can follow bariatric surgery (and is worsened by excessive zinc intake) — causes a myeloneuropathy, damaging both peripheral nerves and the spinal cord, sometimes mimicking B12 deficiency. It is frequently missed precisely because few clinicians think to check it.

Fat-soluble vitamins (especially vitamin E). Impaired fat absorption, more relevant after gallbladder-related changes and malabsorptive procedures, can lead to vitamin E deficiency, which causes a distinct neurological syndrome including neuropathy and balance problems.

Other B vitamins and minerals. Folate, B6, and others can also run low, compounding the picture.

Why it’s so often missed

The delay is the problem. Nutrient stores can take months or years to deplete, so the neuropathy often appears well after the surgery, by which time neither the patient nor a new clinician necessarily connects the two. Copper and vitamin E, in particular, are not on most routine panels, so they go unchecked unless someone specifically thinks of them. A patient can end up labeled with idiopathic neuropathy when the real cause is a treatable, surgery-related deficiency that simply wasn’t on anyone’s radar.

The answer: lifelong monitoring and repletion

The solution is straightforward in principle and requires diligence in practice. Anyone who has had bariatric surgery — and those with malabsorption after other digestive procedures — needs lifelong nutritional monitoring, including the nutrients that routine panels skip. That means periodic checks of B12 (functionally, with MMA and homocysteine), thiamine, copper, and the fat-soluble vitamins including vitamin E, along with folate and others as indicated, and repletion tailored to what testing shows.

Repletion sometimes requires specific forms or routes (for example, higher-dose or non-oral B12) because the absorption problem that caused the deficiency also affects how supplements are absorbed. This is why post-surgical nutritional care is an ongoing medical partnership, not a one-time fix — and when a neuropathy does appear, checking this full panel can reveal a cause that is genuinely correctable.

Where this fits

Post-surgical malabsorption is one of the nutritional/metabolic drivers considered in a complete neuropathy workup. Its signature is the combination of an unexplained neuropathy and a history of digestive surgery — a history worth volunteering to any clinician evaluating nerve symptoms, because it points straight at a set of specific, testable deficiencies.

Frequently asked questions

This is set out in Nutritional deficiencies beyond B12 that damage peripheral nerves.

Key takeaways

• Bariatric and gallbladder surgery can impair nutrient absorption and cause delayed neuropathy.
• Key nutrients at risk: B12, thiamine, copper, and fat-soluble vitamins (especially vitamin E).
• Copper and vitamin E deficiencies are commonly missed because they aren’t on routine panels.
• The delay between surgery and symptoms is why the cause is so often overlooked.
• Lifelong monitoring and tailored repletion can prevent and reverse these deficiencies.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change supplements or medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

References

1. Kumar N. Neurologic complications of bariatric surgery. Continuum (Minneap Minn). 2014.
2. Jaiser SR, Winston GP. Copper deficiency myelopathy and neuropathy. J Neurol. 2010;257:869–881.
3. Becker DA, et al. Neurological complications of nutritional deficiency following bariatric surgery. J Obes. 2012.
4. Kumar N. Nutritional neuropathies (vitamin E, B12, thiamine, copper). Neurol Clin. 2007.